In a study of 71 breast cancer patients receiving non-high-dose anthracycline chemotherapy, serum NT-proBNP level measurements and echocardiography were performed before each cycle, within 24 h of the completion of chemotherapy, and at 3-, 6- and 12-month follow-ups. Here, NPPB is linked to breast carcinoma.